Singapore-based biotech company Immunoscape announced that it has raised $11 million in a global equity financing round led by US-based venture firm Anzu Partners and joined by University of Tokyo Edge Capital (UTEC) in Japan, and NPR Holdings in Indonesia.
The company, which was founded in 2017, said that its immune profiling platform, which provides deep insights into the T-cells of the human...
Sydney, Australia-based tech accelerator BlueChilli and Enterprise Singapore, an economic agency under the Singapore Ministry and Trade and Industry, announced that they will partner to launch a Singapore-based health tech accelerator to spur innovation and build startups that address health challenges and opportunities in Southeast Asia.
BlueChilli has also joined Enterprise Singapore’s Startup...
